Immunogenic cancer cell death: a key-lock paradigm

This publication has 46 references indexed in Scilit:

• The anticancer immune response: indispensable for therapeutic success?
  Journal of Clinical Investigation, 2008
• Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance
  Proceedings of the National Academy of Sciences, 2008
• The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
  Immunological Reviews, 2007
• Calreticulin requires an ancillary adjuvant for the induction of efficient cytotoxic T cell responses
  Molecular Immunology, 2007
• Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
  Nature Medicine, 2007
• Bortezomib enhances dendritic cell (DC)–mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications
  Blood, 2007
• Activation of Poly(ADP)-ribose Polymerase (PARP-1) Induces Release of the Pro-inflammatory Mediator HMGB1 from the Nucleus
  Journal of Biological Chemistry, 2007
• Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
  Nature, 2007
• Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
  The Journal of Experimental Medicine, 2005
• Enhanced expression of heat shock proteins in gradually dying cells and their release from necrotically dead cells
  Experimental Cell Research, 2005